The Diagnostic Dilemma of Charcot Foot in 73 Year-Old-Female


  • Helena Helena Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang
  • Rulli Rosandi Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang



charcot foot, charcot neuroarthropathy (CN)


Charcot neuroarthropathy (CN) is a progressive degenerative arthropathy of weight-bearing joints, which rarely complicates diabetes mellitus, usually in the foot or ankle. Commonly, when affecting the foot, it seems to be determined by the interaction of neuropathy, osteopenia, and proinflammatory cytokines on a calcified peripheral vasculature that maintains its ability to vasodilate despite widespread arteriosclerosis. Although often unrecalled, this arthropathy is probably triggered by trauma. Diagnosis is primarily clinical, given the lack and non-specificity of radiological and biochemical findings at the acute stage. CN should be considered in the differential diagnosis of any diabetic patient presenting with a warm swollen lower extremity. Offloading is essential and improves limb survival. Failure to institute corrective measures at an early stage results in a foot that is prone to deformity, ulceration, amputation, and loss of function. We report a case of Charcot foot in a 73 years old female and review of diagnostic modalities.


Sandro V, and Cachia MJ. Charcot Neuroarthropathy: Pathogenesis, Diagnosis, and Medical Management. Malta Medical Journal. 2008; 20:13-9.

Sommer TC and Thomas HL. Charcot Foot: The Diagnostic Dilemma. American Family Physician. 2001; 64:1591-8. [PMID:11730314]

El-Gafary, Mostafa, Al-adly. The Management of Charcot Joint Disease Affecting the Ankle and Foot by Arthrodesis controlled by an Ilizarov Frame. The Journal of Bone and Joint Surgery. 2009; 91:1322-5. [doi: 10.1302/0301-620X.91B10.22431.]

Gupta, PPK, V Mohan. Update Article Charcot Foot an Update. JAPI. 2003; 51:367-72.

Jeffcoate WJ. Theories concerning the Pathogenesis of the Acute Charcot Foot Suggest Future Therapy. Curr Diab Rep. 2005; 5:430-5. []

Bradley L, Lamm, Paley D. Charcot Neuroarthropathy of the Foot and Ankle in Limb Lengthening and Reconstruction Surgery. Limb Lengthening and Reconstruction Surgery Vol. 1. London: Informa Healthcare. 2007:221-32.

Petrova NL, Foster AV, Edmonds ME. Difference in Presentation of Charcot Osteoarthropathy in Type 1 Compared with Type 2 Diabetes. Diabetes Care. 2004; 27:1235-6.

Jeffcoate WJ, Game F, Cavanagh PR. The Role of Pro-Inflammatory Cytokines in the Cause of Neuropathicosteoarthropathy (acute charcot foot) in diabetes. Lancet. 2005:366:2058-61. Claire MC, Crystal LR, and Thomas Z. Charcot Foot Reconstruction with Combined Internal and External




How to Cite

Helena, H., & Rosandi, R. (2020). The Diagnostic Dilemma of Charcot Foot in 73 Year-Old-Female. Clinical and Research Journal in Internal Medicine, 1(1), crjim, 55–59.